Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Inventory Average: 2016-2025

Historic Inventory Average for Heron Therapeutics (HRTX) over the last 10 years, with Sep 2025 value amounting to $71.5 million.

  • Heron Therapeutics' Inventory Average rose 61.00% to $71.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.5 million, marking a year-over-year increase of 61.00%. This contributed to the annual value of $47.6 million for FY2024, which is 1.46% down from last year.
  • Per Heron Therapeutics' latest filing, its Inventory Average stood at $71.5 million for Q3 2025, which was up 10.08% from $64.9 million recorded in Q2 2025.
  • Heron Therapeutics' 5-year Inventory Average high stood at $71.5 million for Q3 2025, and its period low was $21.1 million during Q1 2024.
  • Moreover, its 3-year median value for Inventory Average was $48.3 million (2023), whereas its average is $46.8 million.
  • Its Inventory Average has fluctuated over the past 5 years, first plummeted by 60.42% in 2024, then skyrocketed by 202.34% in 2025.
  • Over the past 5 years, Heron Therapeutics' Inventory Average (Quarterly) stood at $44.9 million in 2021, then rose by 18.83% to $53.4 million in 2022, then declined by 21.25% to $42.1 million in 2023, then increased by 17.82% to $49.6 million in 2024, then surged by 61.00% to $71.5 million in 2025.
  • Its Inventory Average was $71.5 million in Q3 2025, compared to $64.9 million in Q2 2025 and $55.0 million in Q1 2025.